Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Study to Demonstrate the Efficacy and Safety of Privigen in the Treatment of Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT01184846 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT01184846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01184846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Study to Demonstrate the Efficacy and Safety of Privigen in the Treatment of Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
November 30, 2011
Enrollment
31 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyneuropathy